Skip to Content

Clinical Trials
Patient Portal

Loading component...

Loading component...

SCRI: BRE381: IIT - Ph2 Tucatinib combo w/ doxil for HER2+ mBC

Phase II Clinical Trial

Phase 2 Single Arm Trial with a Safety Lead-in of Tucatinib in Combination with Doxil for the Treatment of HER2+ Metastatic Breast Cancer (BRE 381)

Indication: Breast Cancer

Trial Number: 05748834

Trial Status: OPEN

Learn more about this clinical trial.

About Us
Specialities & Services
Request Appointment
Careers
Contact Us
Media Center
Cancer Support Services
Careopolis

Find a Provider
Find a Location
Clinical Trials
Patient Portal
Patient Forms
Patient Resources
Patient Rights & Privacy
Insurance Information

© 2026 Texas Oncology. All rights reserved.|Privacy Notice|Terms of Use